As the alternative protein industry strives to capture a significant share of the global protein market by 2035, optimizing bioprocessing emerges as a critical task. In an era where innovation is driven by sustainability and efficiency, manufacturers find themselves relying heavily on pump
In recent developments within the biopharmaceutical sector, DuPont has taken a significant step forward by unveiling its latest offering. The introduction of Liveo Pharma TPE Ultra-Low Temp Tubing marks an innovative expansion of DuPont's product line, specifically targeted at the stringent demands
In a groundbreaking initiative, Burjeel Holdings is joining forces with Caring Cross to establish advanced biomanufacturing facilities dedicated to chimeric antigen receptor (CAR)-T cell therapies in the United Arab Emirates (UAE). This collaboration aims to revolutionize the production and
INCOG, a contract development and manufacturing organization (CDMO), recently made a substantial investment to expand its capabilities in the sterile injectables sector. In February 2024, the company committed $75 million to install an Optima syringe and cartridge filling line, projected to be GMP
Recce Pharmaceuticals, a Sydney-based biotechnology company, has successfully raised A$15.8 million to advance its groundbreaking anti-infective drugs into Phase 3 trials. This funding was obtained through a combination of private placement and an entitlement offer. Recce's synthetic
Tango Therapeutics, a biotechnology company specializing in cancer treatments, has taken significant measures to address the challenging financial landscape. Recently, the company announced layoffs affecting approximately 20% of its workforce, a strategic move designed to extend its cash runway. As
